Haptoglobin phenotype : a germline risk factor for malignant pleural mesothelioma? A case-control study

Bron
Clinica chimica acta - ISSN 0009-8981-573 (2025) p. 1-6
Auteur(s)
    Kevin Lamote, Sigurd Delanghe, Marijn M. Speeckaert, Jan van Meerbeeck, Joris R. Delanghe

Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types : a validation study

Bron
EClinicalMedicine - ISSN 2589-5370-82 (2025) p. 1-11
Auteur(s)
    Luigi Lim, Abigirl Machingura, Mekdes Taye, Madeline Pe, Corneel Coens, Francesca Martinelli, Ahu Alanya, Stephanie Antunes, Dongsheng Tu, Ethan Basch, Jolie Ringash, Yvonne Brandberg, Mogens Groenvold, Alexander Eggermont, Fatima Cardoso, Jan van Meerbeeck, Michael Koller, Winette T.A. van der Graaf, Martin J.B. Taphoorn, Johan A.F. Koekkoek, Jaap C. Reijneveld, Riccardo Soffietti, Galina Velikova, Andrew Bottomley, Henning Flechtner, Jammbe Musoro

Bridging the divide : addressing discrepancies between clinical guidelines, policy guidelines, and biomarker utilization

Bron
Diagnosis - ISSN 2194-8011- (2024) p.
Auteur(s)
    Denis Horgan, Paul Hofman, Reinhard Buttner, Olaf Riess, Iwona Lugowska, France Dube, Jaya Singh, Ernest Nadal, Tomasz Stoklosa, Elina Sivina, Marc van der Buckle, Silvia Mosoiu, Luca Bertolaccini, Nicolas Girard, Jan van Meerbeeck, Imran Omar, Ettore D. Capoluongo, Stefan Bielack, Tanya Hills, David Baldwin, Vivek Subbiah